Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study

Background. The use of hypercaloric formulas in cystic fibrosis patients has the risks of negative effects on carbohydrate and lipid metabolism. Thus, it is interesting to analyze the efficacy of malnutrition correction and the safety of hypercaloric enteral products with a low glycemic index and wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiana Y. Maksimycheva, Elena I. Kondratyeva, Victoria D. Sherman, Anna Y. Voronkova, Anna Y. Kulevatova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2021-12-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/2803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688553321136128
author Tatiana Y. Maksimycheva
Elena I. Kondratyeva
Victoria D. Sherman
Anna Y. Voronkova
Anna Y. Kulevatova
author_facet Tatiana Y. Maksimycheva
Elena I. Kondratyeva
Victoria D. Sherman
Anna Y. Voronkova
Anna Y. Kulevatova
author_sort Tatiana Y. Maksimycheva
collection DOAJ
description Background. The use of hypercaloric formulas in cystic fibrosis patients has the risks of negative effects on carbohydrate and lipid metabolism. Thus, it is interesting to analyze the efficacy of malnutrition correction and the safety of hypercaloric enteral products with a low glycemic index and with medium-chain triglycerides content of 50%.Objective. The aim of the study is analyze the efficacy of malnutrition correction with therapeutic hypercaloric product for enteral nutrition in children with cystic fibrosis.Methods. The study included patients aged from 3 to 18 years with malnutrition (BMI < 50 percentile) who were prescribed therapeutic hypercaloric formula to correct the malnutrition. Anthropometric indicators (height, body weight), actual nutritional status, pancreatin doses, lung function, carbohydrate metabolism rates, and cholestasis marker (bile acid concentration) were measured initially and after 1 month of using formula nutrition.Results. The children’ body weight (Me) has increased from 24.5 (21.2; 38.7) to 25.3 kg (21.6; 39.7) (p = 0.001), growth (Me) — from 133.5 (120.2; 146.5) to 136.5 cm (123.0; 148.5) (p < 0.001) after 1 month of using hypercaloric formula. The growth percentile increased from 33 to 40, the z-criterion values — from –0.5 to –0.3 SD (p < 0.001). There was no increase in BMI in dynamics due to the fact that the growth of children was ahead of body weight increase. The daily energy intake increased by an average of 450 kcal that was 21.8% regarding physiological need.Conclusion. The inclusion of hypercaloric formula in the diet of children with cystic fibrosis for 1 month significantly increases the indicators of linear growth and positively affects the overall physical development. There were no negative effect of formula on carbohydrate and lipid metabolism.
format Article
id doaj-art-d68e43c8e8fd474a97443e94a287df4f
institution DOAJ
issn 1682-5527
1682-5535
language English
publishDate 2021-12-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-d68e43c8e8fd474a97443e94a287df4f2025-08-20T03:21:56Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352021-12-01206s58158810.15690/vsp.v20i6S.23662007Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort StudyTatiana Y. Maksimycheva0Elena I. Kondratyeva1Victoria D. Sherman2Anna Y. Voronkova3Anna Y. Kulevatova4Medical Genetic Research Center named after N.P. Bochkov; Research Clinical Institute of Childhood of the Ministry of Health of Moscow RegionMedical Genetic Research Center named after N.P. Bochkov; Research Clinical Institute of Childhood of the Ministry of Health of Moscow RegionMedical Genetic Research Center named after N.P. Bochkov; Research Clinical Institute of Childhood of the Ministry of Health of Moscow RegionMedical Genetic Research Center named after N.P. Bochkov; Research Clinical Institute of Childhood of the Ministry of Health of Moscow RegionResearch Clinical Institute of Childhood of the Ministry of Health of Moscow RegionBackground. The use of hypercaloric formulas in cystic fibrosis patients has the risks of negative effects on carbohydrate and lipid metabolism. Thus, it is interesting to analyze the efficacy of malnutrition correction and the safety of hypercaloric enteral products with a low glycemic index and with medium-chain triglycerides content of 50%.Objective. The aim of the study is analyze the efficacy of malnutrition correction with therapeutic hypercaloric product for enteral nutrition in children with cystic fibrosis.Methods. The study included patients aged from 3 to 18 years with malnutrition (BMI < 50 percentile) who were prescribed therapeutic hypercaloric formula to correct the malnutrition. Anthropometric indicators (height, body weight), actual nutritional status, pancreatin doses, lung function, carbohydrate metabolism rates, and cholestasis marker (bile acid concentration) were measured initially and after 1 month of using formula nutrition.Results. The children’ body weight (Me) has increased from 24.5 (21.2; 38.7) to 25.3 kg (21.6; 39.7) (p = 0.001), growth (Me) — from 133.5 (120.2; 146.5) to 136.5 cm (123.0; 148.5) (p < 0.001) after 1 month of using hypercaloric formula. The growth percentile increased from 33 to 40, the z-criterion values — from –0.5 to –0.3 SD (p < 0.001). There was no increase in BMI in dynamics due to the fact that the growth of children was ahead of body weight increase. The daily energy intake increased by an average of 450 kcal that was 21.8% regarding physiological need.Conclusion. The inclusion of hypercaloric formula in the diet of children with cystic fibrosis for 1 month significantly increases the indicators of linear growth and positively affects the overall physical development. There were no negative effect of formula on carbohydrate and lipid metabolism.https://vsp.spr-journal.ru/jour/article/view/2803cystic fibrosischildrenmalnutritionhypercaloric formulaenteral nutritionbowel syndromemalabsorption
spellingShingle Tatiana Y. Maksimycheva
Elena I. Kondratyeva
Victoria D. Sherman
Anna Y. Voronkova
Anna Y. Kulevatova
Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
Вопросы современной педиатрии
cystic fibrosis
children
malnutrition
hypercaloric formula
enteral nutrition
bowel syndrome
malabsorption
title Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
title_full Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
title_fullStr Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
title_full_unstemmed Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
title_short Results of Malnutrition Correction in Children with Cystic Fibrosis with Hypercaloric Formulas for Enteral Nutrition for One Month: Cohort Study
title_sort results of malnutrition correction in children with cystic fibrosis with hypercaloric formulas for enteral nutrition for one month cohort study
topic cystic fibrosis
children
malnutrition
hypercaloric formula
enteral nutrition
bowel syndrome
malabsorption
url https://vsp.spr-journal.ru/jour/article/view/2803
work_keys_str_mv AT tatianaymaksimycheva resultsofmalnutritioncorrectioninchildrenwithcysticfibrosiswithhypercaloricformulasforenteralnutritionforonemonthcohortstudy
AT elenaikondratyeva resultsofmalnutritioncorrectioninchildrenwithcysticfibrosiswithhypercaloricformulasforenteralnutritionforonemonthcohortstudy
AT victoriadsherman resultsofmalnutritioncorrectioninchildrenwithcysticfibrosiswithhypercaloricformulasforenteralnutritionforonemonthcohortstudy
AT annayvoronkova resultsofmalnutritioncorrectioninchildrenwithcysticfibrosiswithhypercaloricformulasforenteralnutritionforonemonthcohortstudy
AT annaykulevatova resultsofmalnutritioncorrectioninchildrenwithcysticfibrosiswithhypercaloricformulasforenteralnutritionforonemonthcohortstudy